
You are here
Fees and charges: summary from 1 December 2021
The TGA is required to recover its costs for all activities that fall within the scope of the Therapeutic Goods Act 1989, including the TGA's public health responsibilities.
- A fee is charged for a service, such as a product evaluation.
- A charge is a form of tax on regulated industry and is applied annually based on a 1 July to 30 June financial year.
Go to:
- Payment options for information on how to pay
- Information and notices about TGA fees and payments for general information.
This guidance is a summary of fees and charges, which are in the Australian therapeutic goods legislation. This is not an exhaustive list.
For a complete list of all fees and charges and the exact legislative wording, please refer directly to the legislation.
Fees and charges: summary from 1 December 2021
- Fees and charges: summary from 1 December 2021 (pdf,529kb)
- Fees and charges: summary from 1 December 2021 (docx,150kb)
We aim to provide documents in an accessible format. If you're having problems using this document, please contact TGAFeesAndCharges@health.gov.au.
Contents
- Introduction
- Prescription medicines
- Non-prescription medicines
- Manufacturing medicines and OTGs
- Export of therapeutic goods
- Biologicals
- Blood, blood components and HPCs
- Medical devices
- IVD medical devices
- Other listed and registered therapeutic goods (OTGs)
- Clinical trials
- General fees